| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |